OBAI compared with DARE: revenue, margins and what each company keeps, and the suppliers and customers both name

OBAIOur Bond, Inc.

Mkt capRevenueRevenue

DAREDare Bioscience, Inc.

Mkt capRevenueRevenue

Compare

OBAIOur Bond, Inc.

DAREDare Bioscience, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OBAI 1

—largest customerunlistedcustomer

Shared 0

No shared counterparties.

Only DARE 5

OGNOrganoncustomer

—Bravado Pharmaceuticalsunlistedsupplier

—Catalent JNPunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Medvantx

unlistedsupplier

1 more · DARE chain ›

OBAIOur Bond, Inc.

1.68▼−5.62%· post 1.64

Mkt cap$2.2MRevenue$2MQ2 FY26

DAREDare Bioscience, Inc.

0.65▲+4.10%· post 0.64

ClosedNov 6 '26

Mkt cap$9.5MRevenue$187,546Q2 FY26

Compare

ClosedNov 6 '26

OBAIOur Bond, Inc.

DAREDare Bioscience, Inc.

1.68▼−5.62%post 1.64

Price

0.65▲+4.10%post 0.64

$2.2M

Mkt cap

$9.5M

Q2 FY26$2M

Revenue

$187,546Q2 FY26

OBAI1.68▼−5.62%vsDARE0.65▲+4.10%ClosedNov 6 '26